Which has the lower trailing P/E, INCY or STE?

INCY has the lower trailing P/E: INCY trades at 15.85 and STE at 25.52. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, INCY or STE?

Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus STE at 12.13%.

Does INCY or STE pay a bigger dividend?

STE pays a dividend (1.20% yield), while INCY has no payments in the available dividend history.

Is INCY or STE more profitable?

INCY runs the higher net margin — INCY at 27.71% versus STE at 13.33%.

How have INCY and STE total returns compared?

Over the past 10 years, INCY delivered 4.38% and STE delivered 12.75% annualized total return. Past performance doesn't predict future results.

Incyte Corporation (INCY) vs STERIS plc (STE)

A side-by-side comparison of Incyte Corporation and STERIS plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

INCY

Incyte Corporation

$25.22B

$124.44HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT

STE

STERIS plc

$20.35B

$208.77HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT

Total return — INCY vs STE

growth of $100 · dividends reinvested · last 10y

INCY +47.9% (+4.0%/yr)STE +228.7% (+12.6%/yr)STE compounded faster over this window

INCY STE

INCY vs STE: by the numbers

•INCY is the larger company ($25.22B vs $20.35B market cap).
•INCY trades at the lower trailing earnings multiple (15.85 vs 25.52 P/E), one valuation lens rather than an overall verdict.
•INCY converts more revenue to profit (27.71% vs 13.33% net margin).
•INCY grew revenue faster over the past five years (16.43% vs 12.13% CAGR).
•STE pays a dividend (1.20% yield), while INCY has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	INCY	STE
P/E ratio	15.85	25.52
Forward P/E	33.08	18.63
P/S ratio	4.33	3.37
P/B ratio	3.98	2.82
EV / EBITDA	10.99	12.08
FCF yield	7.61%	4.55%

Profitability

Metric	INCY	STE
Gross margin	92.62%	44.43%
Operating margin	31.57%	18.91%
Net margin	27.71%	13.33%
ROE	25.41%	11.17%
ROIC	22.95%	8.74%

Dividends

Metric	INCY	STE
Dividend yield	N/A	1.20%
Payout ratio	N/A	30.81%

Growth (annualized)

Metric	INCY	STE
Revenue CAGR (5Y)	16.43%	12.13%
EPS CAGR (5Y)	21.19%	11.22%
FCF CAGR (5Y)	33.69%	16.89%
Total return CAGR (5Y)	11.30%	1.08%

Frequently asked

Which has the lower trailing P/E, INCY or STE?: INCY has the lower trailing P/E: INCY trades at 15.85 and STE at 25.52. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, INCY or STE?: Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus STE at 12.13%.
Does INCY or STE pay a bigger dividend?: STE pays a dividend (1.20% yield), while INCY has no payments in the available dividend history.
Is INCY or STE more profitable?: INCY runs the higher net margin — INCY at 27.71% versus STE at 13.33%.
How have INCY and STE total returns compared?: Over the past 10 years, INCY delivered 4.38% and STE delivered 12.75% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INCY analysis Full STE analysis Interactive comparison tool

Dig into the metrics

Incyte P/E ratio STERIS P/E ratio STERIS dividend yield Incyte ROE STERIS ROE Incyte operating margin STERIS operating margin Incyte revenue growth STERIS revenue growth Incyte free cash flow STERIS free cash flow

Incyte & STERIS appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.